Version of section 95 from 2019-10-17 to 2023-05-17:
Marginal note:Dissolution and disintegration
95 (1) Each discrete unit of a cannabis product that is intended for ingestion or nasal, rectal or vaginal use must meet, if the form of the unit is similar to a dosage form for which a dissolution or disintegration test is set out in a publication referred to in Schedule B to the Food and Drugs Act, the requirements of the test or, if there is more than one applicable test, the requirements of any such test that is suitable for demonstrating that the cannabis product will perform as intended.
(2) Subsection (1) does not apply to edible cannabis.
- SOR/2019-206, s. 27
- Date modified: